Adverse effects of MVA-T7 on the transport of Marburg virus glycoprotein

Journal of Virological Methods

Volumn 91, Issue 1, 2001, Pages 29-35

  Sanger C ^a   Muhlberger E ^a   Klenk, H D ^a   Becker, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Glycoprotein; Marburg virus; MVA T7

Indexed keywords

DNA DIRECTED RNA POLYMERASE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MARBURG VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; VACCINIA VIRUS; VIRUS RECOMBINANT;

CELL MEMBRANE; ENDOPLASMIC RETICULUM; GENETIC VECTORS; HELA CELLS; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0035154339     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(00)00239-1     Document Type: Article

References (23)

1. Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C
2. Membrane organization of bluetongue virus nonstructural glycoprotein NS3
3. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells
4. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine
5. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line
6. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells
7. Glycosylation and oligomerization of the spike protein of Marburg virus
8. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein
9. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
10. Carbohydrate structure of Marburg virus glycoprotein
11. The lectins: Carbohydrate-binding proteins of plants and animals
12. Induction of recombinant gene expression in stabily transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal (in process citation)
13. Carbohydrates of influenza virus. V. Oligosaccharides attached to individual glycosylation sites of the hemagglutinin of fowl plague virus
14. Secretion of fowl plague virus haemagglutinin from insect cells requires elimination of both hydrophobic domains
15. Vaccination against pox diseases under immunosuppressive conditions
16. The smallpox vaccination strain MVA: Marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)
17. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin
18. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) gag-Pol primes for an anamnestic gag- specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
19. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
20. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
21. Proteolytic processing of Marburg virus glycoprotein
22. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein
23. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells